JSP Pharmaceutical Manufacturing (Thailand) Plc, a company specialising in the distribution of medicines and nutritional supplements, is eyeing a 30% increase in revenue this year, which is partly due to the introduction of its new pharmaceutical research and development (R&D) service for the growing medical industry. In 2020, JSP earned 436 million baht, albeit incurring a loss of 17.4 million baht.
During the first quarter, the firm’s profit reached 1.8 million baht, with revenue amounting to 112.6 million baht. Sittichai Daengprasert, Chief Executive of JSP, believes that the growing domestic medicine industry will lead to a higher demand for pharmaceutical R&D, resulting in a new revenue stream for his company. He said…
“The company is seeking an opportunity in the R&D business by building a new pharmaceutical laboratory to serve small and…
